Xolair
omalizumab
Asthma
Urticaria
Rhinitis
Date of authorisation:
Revision: 50
Last updated:
MedicineHumanAuthorised
Omlyclo
omalizumab
Asthma
Urticaria
Opinion date:
Last updated:
MedicineHumanOpinion
EMEA-002552-PIP01-19 - paediatric investigation plan
Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Gastroentology-Hepatology
PIP number: P/0098/2020
Route(s) of administration: Oral use
Pharmaceutical form(s):
Tablet
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-000735-PIP01-09 - paediatric investigation plan
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Pneumology-allergology
PIP number: P/133/2010
Route(s) of administration: Subcutaneous use
Pharmaceutical form(s):
Powder and solvent for solution for injection
Solution for injection in pre-filled syringe
Decision date:
Last updated:
Compliance check: ✖
PIPHuman